TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

Home・Aandelen Lijst・Genpact Ltd

Genpact Ltd

Gesloten

SectorTechnologie

34.08 -0.18

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

33.12

Max

34.14

Belangrijke statistieken
By Trading Economics
Inkomsten	-2.7M 143M
Verkoop	28M 1.3B
K/W Sectorgemiddelde	10.808 86.001
Dividendrendement	1.98
Winstmarge	10.846
Werknemers	146,500
EBITDA	-29M 201M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+33.57% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	1.98% 2.73%

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-1.9B 5.7B
Vorige openingsprijs	34.26
Vorige sluitingsprijs	34.08

Nieuwssentiment

By Acuity

50%

169 / 374 Rangschikking in Technology

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

4.95 / N/A Steun & Weerstand

Genpact Ltd Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

12 mrt 2026, 11:32 UTC

Winsten

Italian Insurer Generali Posts Rise in Profit -- Update

12 mrt 2026, 11:20 UTC

Winsten

Correction to Generali Flash Headlines

12 mrt 2026, 06:29 UTC

Winsten

Italian Insurer Generali Posts Rise in Profit on Growth Across Segments

15 apr 2026, 06:09 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Generali Could Consider Capital-Light M&A to Grow Franchise, Deputy CEO Says -- Market Talk

12 mrt 2026, 08:27 UTC

Marktinformatie

Generali's AI Disclosure Is Pleasing -- Market Talk

12 mrt 2026, 07:01 UTC

Marktinformatie

Winsten

Generali's Beat Should Get Positive Share Reaction -- Market Talk

12 mrt 2026, 06:04 UTC

Winsten

Generali Backs 2027 View

12 mrt 2026, 06:04 UTC

Winsten

Generali 2025 Life PVNBP EUR55.55B

12 mrt 2026, 06:04 UTC

Winsten

Analysts Saw Generali 2025 Life PVNBP EUR56.03B

12 mrt 2026, 06:04 UTC

Winsten

Analysts Saw Generali 2025 Life New Business Value EUR3.05B

12 mrt 2026, 06:04 UTC

Winsten

Generali 2025 Life New Business Value EUR3.15B

12 mrt 2026, 06:04 UTC

Winsten

Generali End-2025 Solvency Ratio 219%

12 mrt 2026, 06:04 UTC

Winsten

Analysts Saw Generali End-2025 Solvency Ratio 212%

12 mrt 2026, 06:04 UTC

Winsten

Analysts Saw Generali 2025 Undiscounted Combined Ratio 94.2%

12 mrt 2026, 06:04 UTC

Winsten

Analysts Saw Generali 2025 Combined Ratio 92.5%

12 mrt 2026, 06:04 UTC

Winsten

Generali 2025 Combined Ratio 92.6%

12 mrt 2026, 06:04 UTC

Winsten

Generali 2025 Undiscounted Combined Ratio 94.3%

12 mrt 2026, 06:04 UTC

Winsten

Analysts Saw Generali 2025 Dividend EUR1.59

12 mrt 2026, 06:04 UTC

Winsten

Analysts Saw Generali 2025 Adj. Net Pft EUR4.31B

12 mrt 2026, 06:04 UTC

Winsten

Generali Declares Dividend of EUR1.64

12 mrt 2026, 06:04 UTC

Winsten

Generali 2025 Adj. Net Pft EUR4.315B

12 mrt 2026, 06:04 UTC

Winsten

Generali Announces EUR500M Buyback for 2026

12 mrt 2026, 06:04 UTC

Winsten

Generali 2025 Net Inflows EUR16B

12 mrt 2026, 06:04 UTC

Winsten

Generali End-2025 Assets Under Management EUR899.93B

12 mrt 2026, 06:04 UTC

Winsten

Generali 2025 Net Pft EUR4.17B

12 mrt 2026, 06:04 UTC

Winsten

Analysts Saw Generali 2025 Oper Result EUR7.965B

12 mrt 2026, 06:04 UTC

Winsten

Analysts Saw Generali 2025 Net Pft EUR4.225B

12 mrt 2026, 06:04 UTC

Winsten

Generali 2025 Life Written Premiums EUR61.94B

12 mrt 2026, 06:04 UTC

Winsten

Analysts Saw Generali 2025 Life Written Premiums EUR62.795B

12 mrt 2026, 06:04 UTC

Winsten

Generali 2025 Gross Written Premiums EUR98.12B

Peer Vergelijking

Prijswijziging

Genpact Ltd Prognose

Koersdoel

By TipRanks

33.57% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 45.6 USD 33.57%

Hoogste 55 USD

Laagste 37 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Genpact Ltd - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

5 ratings

Buy

Hold

Sell

Gebaseerd op 5 analisten die aandelenratings hebben gegeven aan Genpact Ltd - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

4.95 / N/ASteun & Weerstand

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

169 / 374 Rangschikking in Technologie

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Genpact Ltd

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, and digital commerce; and end-to-end claim lifecycle management, from claims processing and adjudication to claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and customer care support; and direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It also provides digital operation services; data-tech-Al services; finance and accounting services, such as accounts payable, invoice-to-cash, record to report, financial planning and analysis, and enterprise risk and compliance; CFO advisory services; supply chain, and sourcing and procurement services; sales and commercial, and marketing and experience services; and environmental, social and governance services. The company was founded in 1997 and is based in Hamilton, Bermuda.